FDA Guidance on conduct of clinical trials of medical products during COVID-19
Fernanda Lessa - 18:57, 16 de April de 2020840
0
This guidance aims to provide general consideration to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice, and minimizing risks to trial integrity during COVID-19 pandemic.